2023-10-19-硅谷银行-健康科技的未来2023（英）_27页_2mb

Healthtech Investment Trends in 2023

Economic Context

The 2023 healthtech report highlights an economically challenging year due to inflation and interest rate hikes, with public markets showing stabilization. Overall investment decreased from previous highs, marked by fewer deals, slower investment pace, and downward pressure on valuations. Companies faced scrutiny on profitability and unit economics, leading many to revise growth projections and cut costs.

Key Investment Challenges

• Reduced deal volume and smaller check sizes globally.
• Downward valuation shifts, with a rise in flat or down rounds, particularly affecting late-stage companies that had to reassess funding strategies.
• Investment rebounded slightly after late 2022, but valuations aligned more with achievable growth targets.

Positive Trends and Growth Areas

• Resilience in healthtech: Public markets improved, and M&A activity increased, signaling a stabilization.
• Value-based care (VBC) emerged as a bright spot, with strategic acquisitions driving growth.
• Geographic focus: The Bay Area remains dominant in investment, though other regions like Boston and New York saw dips.
• Subsector growth: Provider operations, clinical trial enablement, and alternative care showed investment increases; VBC-enabled companies gained traction through partnerships with payers and retailers.

Future Outlook

Despite ongoing economic uncertainty, the innovation economy remains resilient. Optimism centers on the potential for innovative companies to adapt, with VBC expanding and technology solutions addressing healthcare inefficiencies. Expected increases in deal activity in the latter half of 2023.

Summary

The report underscores a shift toward sustainable investments and market corrections, with healthtech poised for long-term growth through strategic innovation and collaboration.